PAREXEL International Corporation (PRXL) Position Cut by Congress Asset Management Co. MA

Congress Asset Management Co. MA reduced its stake in shares of PAREXEL International Corporation (NASDAQ:PRXL) by 99.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,773 shares of the medical research company’s stock after selling 811,782 shares during the period. Congress Asset Management Co. MA’s holdings in PAREXEL International Corporation were worth $241,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of PRXL. Public Employees Retirement System of Ohio increased its stake in PAREXEL International Corporation by 4.5% in the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock worth $108,000 after buying an additional 73 shares during the last quarter. Meadow Creek Investment Management LLC increased its stake in PAREXEL International Corporation by 7.1% in the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock worth $125,000 after buying an additional 132 shares during the last quarter. Invictus RG acquired a new stake in PAREXEL International Corporation during the first quarter worth approximately $158,000. Glen Harbor Capital Management LLC increased its stake in PAREXEL International Corporation by 7.1% in the first quarter. Glen Harbor Capital Management LLC now owns 2,520 shares of the medical research company’s stock worth $159,000 after buying an additional 168 shares during the last quarter. Finally, Elkfork Partners LLC increased its stake in PAREXEL International Corporation by 7.1% in the first quarter. Elkfork Partners LLC now owns 3,060 shares of the medical research company’s stock worth $193,000 after buying an additional 204 shares during the last quarter. Hedge funds and other institutional investors own 91.58% of the company’s stock.

Shares of PAREXEL International Corporation (NASDAQ:PRXL) opened at 87.66 on Friday. The firm has a 50-day moving average of $87.43 and a 200-day moving average of $74.60. PAREXEL International Corporation has a 1-year low of $51.16 and a 1-year high of $87.86. The firm has a market capitalization of $4.45 billion, a PE ratio of 38.53 and a beta of 0.79.

ILLEGAL ACTIVITY NOTICE: This story was first published by BNB Daily and is owned by of BNB Daily. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.baseball-news-blog.com/2017/08/19/parexel-international-corporation-prxl-shares-sold-by-congress-asset-management-co-ma-updated-updated.html.

A number of analysts recently commented on the stock. Zacks Investment Research downgraded shares of PAREXEL International Corporation from a “buy” rating to a “hold” rating in a report on Thursday. BidaskClub downgraded shares of PAREXEL International Corporation from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 28th. Jefferies Group LLC reissued a “hold” rating and issued a $88.10 target price on shares of PAREXEL International Corporation in a research report on Wednesday, June 21st. Raymond James Financial, Inc. raised shares of PAREXEL International Corporation from an “underperform” rating to a “mkt perform” rating in a research report on Tuesday, June 20th. Finally, Barclays PLC downgraded shares of PAREXEL International Corporation from an “overweighr” rating to an “equal weight” rating and set a $87.00 target price on the stock. in a research report on Tuesday, June 20th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $75.93.

PAREXEL International Corporation Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Receive News & Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply